These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24375999)

  • 21. Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States.
    Stranges PM; Hutton DW; Collins CD
    Value Health; 2013; 16(2):297-304. PubMed ID: 23538181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.
    Lee CH; Patino H; Stevens C; Rege S; Chesnel L; Louie T; Mullane KM
    J Antimicrob Chemother; 2016 Oct; 71(10):2964-71. PubMed ID: 27432604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
    Carignan A; Poulin S; Martin P; Labbé AC; Valiquette L; Al-Bachari H; Montpetit LP; Pépin J
    Am J Gastroenterol; 2016 Dec; 111(12):1834-1840. PubMed ID: 27619835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
    Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.
    Salgado CD; Giannetta ET; Farr BM
    Infect Control Hosp Epidemiol; 2004 May; 25(5):413-7. PubMed ID: 15188848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
    Louie T; Nord CE; Talbot GH; Wilcox M; Gerding DN; Buitrago M; Kracker H; Charef P; Cornely OA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6266-73. PubMed ID: 26248357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum vancomycin concentrations after oral and intracolonic vancomycin administration in a patient with colonic discontinuity and severe
    Wilke K; Helbig S; de With K
    Am J Health Syst Pharm; 2018 May; 75(9):e189-e193. PubMed ID: 29691261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.
    Russo A; Falcone M; Fantoni M; Murri R; Masucci L; Carfagna P; Ghezzi MC; Posteraro B; Sanguinetti M; Venditti M
    Clin Microbiol Infect; 2015 May; 21(5):493.e1-4. PubMed ID: 25698658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.
    Caroff DA; Menchaca JT; Zhang Z; Rhee C; Calderwood MS; Kubiak DW; Yokoe DS; Klompas M
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):662-667. PubMed ID: 31030679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk estimation for recurrent Clostridium difficile infection based on clinical factors.
    D'Agostino RB; Collins SH; Pencina KM; Kean Y; Gorbach S
    Clin Infect Dis; 2014 May; 58(10):1386-93. PubMed ID: 24599770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
    Vega AD; Heil EL; Blackman AL; Banoub M; Kristie Johnson J; Leekha S; Claeys KC
    Pharmacotherapy; 2020 May; 40(5):398-407. PubMed ID: 32246501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.